Ardent Health (ARDT) EPS (Weighted Average and Diluted) (2023 - 2026)

Ardent Health has reported EPS (Weighted Average and Diluted) for 4 years, with the latest figure at $0.28 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 3.45% year-over-year to $0.28; the trailing twelve-month figure through Mar 2026 stood at $0.95 (down 42.77% YoY), and the FY2025 full-year result was $0.96, down 39.24% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.28, down from $0.32 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $0.84 in Q4 2024, with the low at -$0.17 in Q3 2025.
• Average EPS (Weighted Average and Diluted) over 4 years is $0.27, with a median of $0.27 recorded in 2023.
• Year-over-year, EPS (Weighted Average and Diluted) jumped 2900.0% in 2024 and plunged 189.47% in 2025.
• Tracing ARDT's EPS (Weighted Average and Diluted) over 4 years: stood at -$0.03 in 2023, then jumped by 2900.0% to $0.84 in 2024, then tumbled by 61.9% to $0.32 in 2025, then retreated by 12.5% to $0.28 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.28 (Q1 2026), $0.32 (Q4 2025), and -$0.17 (Q3 2025), per Business Quant data.

Peer Comparison